Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 21, 2012; 18(19): 2383-2389
Published online May 21, 2012. doi: 10.3748/wjg.v18.i19.2383
Published online May 21, 2012. doi: 10.3748/wjg.v18.i19.2383
Figure 2 Antiproliferative effect of hexahydrocurcumin and 5-fluorouracil on HT-29 human colon cancer cells.
HT-29 cells were exposed to different concentrations of 5-fluorouracil (5-FU) (A) and hexahydrocurcumin (HHC) (B) for 24-48 h and then cell viability was measured by 5-diphenyltetrazolium bromide assay. 5-FU or HHC significantly decreased cell viability concentration-dependently. Data are expressed as mean ± SE. aP < 0.05 vs control (n = 3).
- Citation: Srimuangwong K, Tocharus C, Yoysungnoen Chintana P, Suksamrarn A, Tocharus J. Hexahydrocurcumin enhances inhibitory effect of 5-fluorouracil on HT-29 human colon cancer cells. World J Gastroenterol 2012; 18(19): 2383-2389
- URL: https://www.wjgnet.com/1007-9327/full/v18/i19/2383.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i19.2383